Royalty Pharma PLC (NASDAQ:RPRX)

43.20
Delayed Data
As of Jun 24
 +2.12 / +5.16%
Today’s Change
34.86
Today|||52-Week Range
44.75
+8.41%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
New Ventures Llc /venture Capital/
Director
Sale6/29/2021479,800$41.26$19.8M+5.03%
New Ventures Llc /venture Capital/
Director
Sale6/28/2021167,448$42.11$7.1M+3.10%
Riggs Rory Balfour
Director
Sale5/20/2022123,696$39.28$4.9M+9.31%
Reddoch James F
Chief Scientific Officer & EVP
Sale6/08/2022100,000$41.56$4.2M+4.12%
Lloyd George /royalty/
Sale5/23/2022100,000$40.27$4.0M+7.87%
Lloyd George /royalty/
Sale11/17/202184,148$42.39$3.6M+1.69%
Lloyd George /royalty/
Sale5/26/202286,026$40.21$3.5M+7.97%
Reddoch James F
Chief Scientific Officer & EVP
Sale5/27/202275,000$41.08$3.1M+4.68%
Lloyd George /royalty/
Sale11/16/202172,659$42.33$3.1M+2.88%
Reddoch James F
Chief Scientific Officer & EVP
Sale5/19/202275,000$40.44$3.0M+8.60%
Page of 6